Relay Therapeutics Inc.
RLAY | NASDAQ
$18.55
+$0.36 (+1.98%)
Sep 22, 2026, 1:35 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 350K | 3M | 7M | n/a | 677K | 7.68M | n/a | n/a | n/a | 10.01M | -1K | 25.2M | 119K | 226K | 253K | 344K | 365K | 419K | 567K | 666K | 844K | 952K |
Cost of Revenue | n/a | 504K | 599K | 67.89M | 61.47M | n/a | 64.43M | 76.62M | 91.99M | 82.4M | 73.87M | 81.49M | 88.2M | 82.83M | 63.93M | 66.9M | 60.51M | 51.67M | 51.08M | 44.16M | 45.15M | 30.62M |
Gross Profit | 350K | 2.5M | 6.4M | -67.89M | -60.8M | 7.68M | -64.43M | -76.62M | -91.99M | -72.4M | -73.87M | -56.29M | -88.08M | -82.6M | -63.67M | -66.56M | -60.15M | -51.25M | -50.51M | -43.49M | -44.3M | -29.67M |
Operating Income | -90.82M | -78.59M | -60.63M | -80.39M | -76.85M | -84.87M | -84.98M | -96.37M | -100.76M | -90.36M | -92.2M | -73.58M | -106.05M | -101.18M | -72.85M | -85.89M | -77.81M | -62.72M | -67.72M | -60.99M | -193.58M | -42.41M |
Interest Income | 7.12M | 5.35M | 5.71M | 6.41M | 7.11M | 7.81M | 8.97M | 8.27M | 8.55M | 8.95M | 8.7M | 7.85M | 7.56M | 6.94M | 5.37M | 1.71M | 1.01M | 696K | 267K | 157K | 180K | 226K |
Pretax Income | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M | -77.07M | -76M | -88.11M | -92.21M | -81.39M | -83.5M | -65.73M | -98.51M | -94.24M | -67.5M | -84.17M | -76.79M | -62.05M | -67.46M | -60.83M | -193.4M | -42.18M |
Net Income | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M | -77.07M | -76M | -88.11M | -92.21M | -81.39M | -83.5M | -65.73M | -98.51M | -94.24M | -67.5M | -84.17M | -76.79M | -62.05M | -67.46M | -60.83M | -193.4M | -42.18M |
Selling & General & Admin | 14.69M | 11.03M | 12.96M | 12.5M | 13.75M | 18.74M | 20.55M | 19.75M | 20.14M | 19.8M | 20.4M | 18.49M | 20.12M | 19.58M | 19.72M | 16.07M | 17.47M | 16.07M | 15.47M | 15.5M | 14.42M | 12.74M |
Research & Development | 76.48M | 70.56M | 55.42M | 68.26M | 63.9M | 73.81M | 68.08M | 76.62M | 91.99M | 82.4M | 77.5M | 81.49M | 88.2M | 82.83M | 67.28M | 66.9M | 60.51M | 51.67M | 51.91M | 44.97M | 168.15M | 30.62M |
Other Expenses | n/a | -504K | -1.35M | -68.26M | -61.6M | n/a | -68.08M | -76.62M | -103.37M | -84.24M | -79.56M | -82.69M | -90.35M | -83.83M | -77.82M | -63.64M | -60.31M | -56.26M | -50.17M | -42.97M | -33.29M | -30.62M |
Operating Expenses | 91.17M | 81.09M | 67.03M | 12.5M | 16.05M | 92.55M | 20.55M | 19.75M | 8.77M | 17.97M | 18.33M | 17.29M | 17.97M | 18.58M | 9.18M | 19.34M | 17.67M | 11.47M | 17.21M | 17.5M | 149.28M | 12.74M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 427K | 144K | n/a | 4.24M | n/a | n/a | n/a | 4.25M | n/a | n/a | n/a | 4.24M | n/a | n/a | n/a | 1.08M | 1.07M | n/a | n/a |
Cost & Expenses | 91.17M | 81.59M | 67.63M | 80.39M | 77.52M | 92.55M | 84.98M | 96.37M | 100.76M | 100.37M | 92.2M | 98.78M | 106.17M | 101.4M | 73.1M | 86.24M | 78.18M | 63.14M | 68.29M | 61.66M | 194.42M | 43.36M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 202.85M | 179.85M | 171.59M | 172.39M | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
Shares Outstanding (Diluted) | 202.85M | 179.85M | 171.59M | 172.39M | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
EPS (Basic) | -0.41 | -0.41 | -0.32 | -0.43 | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 | -0.66 | -2.10 | -0.47 |
EPS (Diluted) | -0.41 | -0.41 | -0.32 | -0.43 | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 | -0.66 | -2.10 | -0.47 |
EBITDA | -82.84M | -72.79M | -57.85M | -73.4M | -69.37M | -75.86M | -74.67M | -86.74M | -110.76M | -90.8M | -92.89M | -73.41M | -106.87M | -100.98M | -82.23M | -81.6M | -76.66M | -66.34M | -64.95M | -57.98M | -57.77M | -41.49M |
EBIT | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M | -77.07M | -76M | -88.11M | -112.13M | -92.2M | -94.26M | -74.78M | -108.2M | -102.18M | -83.4M | -82.63M | -77.61M | -67.32M | -65.99M | -58.99M | -58.73M | -42.41M |
Depreciation & Amortization | 864K | 504K | -2.96M | 748K | 1M | 1.21M | 1.33M | 1.37M | 1.37M | 1.4M | 1.38M | 1.36M | 1.33M | 1.2M | 1.17M | 1.03M | 956K | 975K | 1.03M | 1.01M | 960K | 919K |
Add to Watchlist
Select watchlists to add or remove RLAY